Insulet Inventory 2010-2025 | PODD
Insulet inventory from 2010 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
- Insulet inventory for the quarter ending March 31, 2025 was $0.441B, a 2.37% increase year-over-year.
- Insulet inventory for 2024 was $0.43B, a 6.91% increase from 2023.
- Insulet inventory for 2023 was $0.403B, a 16.09% increase from 2022.
- Insulet inventory for 2022 was $0.347B, a 14.38% increase from 2021.
| Insulet Annual Inventory (Millions of US $) |
|
|---|---|
| 2024 | $430 |
| 2023 | $403 |
| 2022 | $347 |
| 2021 | $303 |
| 2020 | $154 |
| 2019 | $101 |
| 2018 | $71 |
| 2017 | $34 |
| 2016 | $36 |
| 2015 | $12 |
| 2014 | $13 |
| 2013 | $9 |
| 2012 | $15 |
| 2011 | $12 |
| 2010 | $11 |
| 2009 | $10 |
| Insulet Quarterly Inventory (Millions of US $) |
|
|---|---|
| 2025-03-31 | $441 |
| 2024-12-31 | $430 |
| 2024-09-30 | $445 |
| 2024-06-30 | $431 |
| 2024-03-31 | $431 |
| 2023-12-31 | $403 |
| 2023-09-30 | $411 |
| 2023-06-30 | $411 |
| 2023-03-31 | $386 |
| 2022-12-31 | $347 |
| 2022-09-30 | $328 |
| 2022-06-30 | $320 |
| 2022-03-31 | $315 |
| 2021-12-31 | $303 |
| 2021-09-30 | $259 |
| 2021-06-30 | $198 |
| 2021-03-31 | $170 |
| 2020-12-31 | $154 |
| 2020-09-30 | $125 |
| 2020-06-30 | $104 |
| 2020-03-31 | $96 |
| 2019-12-31 | $101 |
| 2019-09-30 | $90 |
| 2019-06-30 | $85 |
| 2019-03-31 | $74 |
| 2018-12-31 | $71 |
| 2018-09-30 | $58 |
| 2018-06-30 | $41 |
| 2018-03-31 | $26 |
| 2017-12-31 | $34 |
| 2017-09-30 | $35 |
| 2017-06-30 | $34 |
| 2017-03-31 | $34 |
| 2016-12-31 | $36 |
| 2016-09-30 | $33 |
| 2016-06-30 | $24 |
| 2016-03-31 | $14 |
| 2015-12-31 | $12 |
| 2015-09-30 | $13 |
| 2015-06-30 | $23 |
| 2015-03-31 | $20 |
| 2014-12-31 | $13 |
| 2014-09-30 | $10 |
| 2014-06-30 | $9 |
| 2014-03-31 | $10 |
| 2013-12-31 | $9 |
| 2013-09-30 | $5 |
| 2013-06-30 | $6 |
| 2013-03-31 | $9 |
| 2012-12-31 | $15 |
| 2012-09-30 | $15 |
| 2012-06-30 | $16 |
| 2012-03-31 | $15 |
| 2011-12-31 | $12 |
| 2011-09-30 | $13 |
| 2011-06-30 | $16 |
| 2011-03-31 | $12 |
| 2010-12-31 | $11 |
| 2010-09-30 | $13 |
| 2010-06-30 | $10 |
| 2010-03-31 | $7 |
| 2009-12-31 | $10 |
| 2009-09-30 | $9 |
| 2009-06-30 | $10 |
| 2009-03-31 | $15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $21.511B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.094B | 27.91 |
| Boston Scientific (BSX) | United States | $148.004B | 37.05 |
| Stryker (SYK) | United States | $145.912B | 30.51 |
| EssilorLuxottica (ESLOY) | France | $130.051B | 0.00 |
| Medtronic (MDT) | Ireland | $112.158B | 15.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.407B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.971B | 27.90 |
| ResMed (RMD) | United States | $36.801B | 27.64 |
| Agilent Technologies (A) | United States | $33.162B | 21.62 |
| GE HealthCare Technologies (GEHC) | United States | $32.817B | 15.58 |
| Terumo (TRUMY) | Japan | $26.665B | 34.63 |
| Koninklijke Philips (PHG) | Netherlands | $22.070B | 15.86 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.366B | 11.80 |
| Baxter (BAX) | United States | $15.831B | 11.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.086B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.138B | 21.36 |
| Lantheus Holdings (LNTH) | United States | $5.758B | 14.52 |
| Prestige Consumer Healthcare (PBH) | United States | $4.234B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.598B | 9.12 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.442B | 15.68 |
| ICU Medical (ICUI) | United States | $3.353B | 24.73 |
| Envista Holdings (NVST) | United States | $3.224B | 26.79 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.043B | 14.05 |
| LeMaitre Vascular (LMAT) | United States | $1.883B | 42.08 |
| AtriCure (ATRC) | United States | $1.692B | 0.00 |
| Acuren (TIC) | United States | $1.348B | 0.00 |
| Neogen (NEOG) | United States | $1.198B | 15.33 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.132B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.087B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.082B | 24.33 |
| Phibro Animal Health (PAHC) | United States | $0.982B | 12.55 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.644B | 0.00 |
| Evolus (EOLS) | United States | $0.622B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.08 |
| Capricor Therapeutics (CAPR) | United States | $0.611B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.581B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.413B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.351B | 12.91 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.327B | 58.20 |
| Canopy Growth (CGC) | Canada | $0.298B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Cresco Labs (CRLBF) | United States | $0.263B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 11.89 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.258B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.215B | 6.05 |
| OraSure Technologies (OSUR) | United States | $0.214B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.05 |
| Quanterix (QTRX) | United States | $0.196B | 0.00 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.08 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.184B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.40 |
| Vireo Growth (VREOF) | United States | $0.129B | 0.00 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.50 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.43 |
| United-Guardian (UG) | United States | $0.038B | 13.25 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |